Palaia G, Pippi
R, Rocchetti F, Caputo M, Macali F, Mohsen A, Del Vecchio A, Tenore G, Romeo U.
Liquid biopsy in the assessment of microRNAs in oral squamous cell carcinoma: A
systematic review. J Clin Exp Dent. 2022;14(10):e875-84.
doi:10.4317/jced.59773
https://doi.org/10.4317/jced.59773
___________
References
|
1.
Pires FR, Ramos AB, Oliveira JB, Tavares AS, Luz PS, Santos TC. Oral squamous
cell carcinoma: clinicopathological features from 346 cases from a single
oral pathology service during an 8-year period. J Appl Oral Sci. 2013;21:460-467. |
|
|
|
|
|
2.
Ferlay J, Soerjomataram II, Dikshit R, Eser S, Mathers C, Rebelo M, et al.
Cancer incidence and mortality worldwide: Sources, methods and major patterns
in GLOBOCAN 2012. Int. J. Cancer 2015;136:E359-E386. |
|
|
|
|
|
3.
Arantes LMRB, De Carvalho AC, Melendez ME, Carvalho AL. Serum, plasma and
saliva biomarkers for head and neck cancer. Expert Rev. Mol. Diagn. 2018;18:85-112. |
|
|
|
|
|
4.
Cristaldi M, Mauceri R, Di Fede O, Giuliana G, Campisi G, Panzarella V.
Salivary Biomarkers for Oral Squamous Cell Carcinoma Diagnosis and Follow-Up:
Current Status and Perspectives. Front Physiol. 2019;10:1476. |
|
|
|
|
|
5.
Weber JA, Baxter DH, Zhang S, Huang DY, Huang KH, Lee MJ, et al. The microRNA
spectrum in 12 body fluids. Clinical chemistry. 2010;56:1733-1741 |
|
|
|
|
|
6.
Detassis S, Grasso M, Del Vescovo V, Denti MA. microRNAs Make the Call in
Cancer Personalized Medicine. Front Cell Dev Biol. 2017;22:5:86 |
|
|
|
|
|
7.
Galamb O, Barták BK, Kalmár A, Nagy ZB, Szigeti KA, Tulassay Z, Igaz P,
Molnár B. Diagnostic and prognostic potential of tissue and circulating long
non-coding RNAs in colorectal tumors. World J Gastroenterol. 2019;25:5026-5048 |
|
|
|
|
|
8.
Guibert N, Pradines A, Favre G, Mazieres J. Current and future applications
of liquid biopsy in nonsmall cell lung cancer from early to advanced stages.
Eur Respir Rev. 2020;29:190052. |
|
|
|
|
|
9.
Giannopoulou L, Zavridou M, Kasimir-Bauer S, Lianidou ES. Liquid biopsy in
ovarian cancer: the potential of circulating miRNAs and exosomes. Transl Res.
2019;205:77-91. |
|
|
|
|
|
10.
Cayrefourcq L, Alix-Panabières C. Clinical relevance of liquid biopsy in
breast cancer: update in 2020. Expert Rev Mol Diagn. 2020;20:913-919 |
|
|
|
|
|
11.
Mazumder S, Datta S, Ray JG, Chaudhuri K, Chatterjee R. Liquid biopsy: miRNA
as a potential biomarker in oral cancer. Cancer Epidemiol. 2019;58:137-145. |
|
|
|
|
|
12.
Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting
items for systematic reviews and meta-analyses: the PRISMA statement. BMJ.
2009; 339:b2535. |
|
|
|
|
|
13.
Chang YA, Weng SL, Yang SF, Chou CH, Huang WC, Tu SJ, et al. A Three-MicroRNA
Signature as a Potential Biomarker for the Early Detection of Oral Cancer.
Int J Mol Sci. 2018;19:758. |
|
|
|
|
|
14.
Liu CJ, Tsai MM, Tu HF, Lui MT, Cheng HW, Lin SC. miR-196a overexpression and
miR-196a2 gene polymorphism are prognostic predictors of oral carcinoma. Ann
Surg Oncol. 2013;20:S406-14. |
|
|
|
|
|
15.
Liu CJ, Lin JS, Cheng HW, Hsu YH, Cheng CY, Lin SC. Plasma miR-187* is a
potential biomarker for oral carcinoma. Clin Oral Investig. 2017;21:1131-1138. |
|
|
|
|
|
16.
Liu CJ, Kao SY, Tu HF, Tsai MM, Chang KW, Lin SC. Increase of microRNA miR-31
level in plasma could be a potential marker of oral cancer. Oral Dis. 2010;16:360-4. |
|
|
|
|
|
17.
Lu YC, Chang JT, Huang YC, Huang CC, Chen WH, Lee LY, et al. Combined
determination of circulating miR-196a and miR-196b levels produces high
sensitivity and specificity for early detection of oral cancer. Clin Biochem.
2015;48:115-21. |
|
|
|
|
|
18.
Mahmood N, Hanif M, Ahmed A, Jamal Q, Mushtaq S, Khan A, et al. Circulating
miR-21 as a prognostic and predictive biomarker in oral squamous cell carcinoma.
Pak J Med Sci. 2019;35:1408-1412. |
|
|
|
|
|
19.
Pedersen NJ, Jensen DH, Lelkaitis G, Kiss K, Charabi BW, Ullum H, et al.
MicroRNA-based classifiers for diagnosis of oral cavity squamous cell
carcinoma in tissue and plasma. Oral Oncol. 2018;83:46-52. |
|
|
|
|
|
20.
Sun G, Cao Y, Wang P, Song H, Bie T, Li M, et al. miR-200b-3p in plasma is a
potential diagnostic biomarker in oral squamous cell carcinoma. Biomarkers.
2018;23:137-141. |
|
|
|
|
|
21.
Tachibana H, Sho R, Takeda Y, Zhang X, Yoshida Y, Narimatsu H, et al.
Circulating miR-223 in Oral Cancer: Its Potential as a Novel Diagnostic
Biomarker and Therapeutic Target. PLoS One. 2016;11:e0159693. |
|
|
|
|
|
22.
Yang CC, Hung PS, Wang PW, Liu CJ, Chu TH, Cheng HW, et al. miR-181 as a
putative biomarker for lymph-node metastasis of oral squamous cell carcinoma.
J Oral Pathol Med. 2011;40:397-404. |
|
|
|
|
|
23.
De Souza MG, de Jesus SF, Santos EM, Gomes ESB, de Paulo Santiago Filho A,
Santos EMS, et al. Radiation Therapy Reduced Blood Levels of LDH, HIF-1α, and
miR-210 in OSCC. Pathol Oncol Res. 2020;26(1):433-442. |
|
|
|
|
|
24.
Emami N, Mohamadnia A, Mirzaei M, Bayat M, Mohammadi F, Bahrami N. miR-155, miR-191,
and miR-494 as diagnostic biomarkers for oral squamous cell carcinoma and the
effects of Avastin on these biomarkers. J Korean Assoc Oral Maxillofac Surg.
2020;46:341-347. |
|
|
|
|
|
25.
Ries J, Vairaktaris E, Agaimy A, Kintopp R, Baran C, Neukam FW, et al.
miR-186, miR-3651 and miR-494: potential biomarkers for oral squamous cell
carcinoma extracted from whole blood. Oncol Rep. 2014;31:1429-36. |
|
|
|
|
|
26.
Ries J, Baran C, Wehrhan F, Weber M, Neukam FW, Krautheim-Zenk A, et al.
Prognostic significance of altered miRNA expression in whole blood of OSCC
patients. Oncol Rep. 2017;37:3467-3474. |
|
|
|
|
|
27.
Ries J, Baran C, Wehrhan F, Weber M, Motel C, Kesting M, Nkenke E. The
altered expression levels of miR-186, miR-494 and miR-3651 in OSCC tissue
vary from those of the whole blood of OSCC patients. Cancer Biomark. 2019;24:19-30. |
|
|
|
|
|
28.
Chen L, Hu J, Pan L, Yin X, Wang Q, Chen H. Diagnostic and prognostic value
of serum miR-99a expression in oral squamous cell carcinoma. Cancer Biomark.
2018;23:333-339. |
|
|
|
|
|
29.
Karimi A, Bahrami N, Sayedyahossein A, Derakhshan S. Evaluation of
circulating serum 3 types of microRNA as biomarkers of oral squamous cell carcinoma;
A pilot study. J Oral Pathol Med. 2020;49:43-48. |
|
|
|
|
|
30.
Li C, Feng Y, Shao W. Changes of serum miR-223-3p in patients with oral cancer
treated with TPF regimen and the prognosis. Oncol Lett. 2020;19:2527-2532. |
|
|
|
|
|
31.
Maclellan SA, Lawson J, Baik J, Guillaud M, Poh CF, Garnis C. Differential
expression of miRNAs in the serum of patients with high-risk oral lesions.
Cancer Med. 2012;1:268-74. |
|
|
|
|
|
32.
Shi J, Bao X, Liu Z, Zhang Z, Chen W, Xu Q. Serum miR-626 and miR-5100 are
Promising Prognosis Predictors for Oral Squamous Cell Carcinoma.
Theranostics. 2019;9:920-931. |
|
|
|
|
|
33.
Singh P, Srivastava AN, Sharma R, Mateen S, Shukla B, Singh A, et al.
Circulating MicroRNA-21 Expression as a Novel Serum Biomarker for Oral
Sub-Mucous Fibrosis and Oral Squamous Cell Carcinoma. Asian Pac J Cancer
Prev. 2018;19:1053-1057. PMid:29699056
PMCid:PMC6031776 |
|
|
|
|
|
34.
Sun L, Liu L, Fu H, Wang Q, Shi Y. Association of Decreased Expression of
Serum miR-9 with Poor Prognosis of Oral Squamous Cell Carcinoma Patients. Med
Sci Monit. 2016;22:289-94. |
|
|
|
|
|
35.
Wen J, Xu H, Liu R, Chen Q, Dai Y, Xu Y. MiR-92b as a marker for TPF induced
chemotherapy response prediction and prognosis evaluation in with advanced
oral squamous cell carcinoma patients. Cell Mol Biol (Noisy-le-grand).
2020;66:24-31. |
|
|
|
|
|
36.
Xu H, Yang Y, Zhao H, Yang X, Luo Y, Ren Y, et al. Serum miR-483-5p: a novel
diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
Tumour Biol. 2016;37:447-53. |
|
|
|
|
|
37.
Dong G, Chen H, Shi Y, Jiang C, Yang H. MicroRNA-758 Regulates Oral Squamous
Cell Carcinoma via COX-2. Indian J Surg. 2021;83:932-938. |
|
|
|
|
|
38.
Duz MB, Karatas OF, Guzel E, Turgut NF, Yilmaz M, Creighton CJ, et al.
Identification of miR-139-5p as a saliva biomarker for tongue squamous cell
carcinoma: a pilot study. Cell Oncol (Dordr). 2016;39:187-93. |
|
|
|
|
|
39.
Gai C, Camussi F, Broccoletti R, Gambino A, Cabras M, Molinaro L, et al.
Salivary extracellular vesicle-associated miRNAs as potential biomarkers in
oral squamous cell carcinoma. BMC Cancer. 2018;18:439. |
|
|
|
|
|
40.
He L, Ping F, Fan Z, Zhang C, Deng M, Cheng B, et al. Salivary exosomal
miR-24-3p serves as a potential detective biomarker for oral squamous cell
carcinoma screening. Biomed Pharmacother. 2020;121:109553. |
|
|
|
|
|
41.
Park NJ, Zhou H, Elashoff D, Henson BS, Kastratovic DA, Abemayor E, et al.
Salivary microRNA: discovery, characterization, and clinical utility for oral
cancer detection. Clin Cancer Res. 2009;15:5473-5477. |
|
|
|
|
|
42.
Liu CJ, Lin SC, Yang CC, Cheng HW, Chang KW. Exploiting salivary miR-31 as a
clinical biomarker of oral squamous cell carcinoma. Head Neck. 2012;34:219-24. |
|
|
|
|
|
43.
Mehdipour M, Shahidi M, Manifar S, et al. Diagnostic and prognostic relevance
of salivary microRNA-21, -125a, -31 and -200a levels in patients with oral
lichen planus - a short report. Cell Oncol. 2018;41:329-334. |
|
|
|
|
|
44.
Momen-Heravi F, Trachtenberg AJ, Kuo WP, Cheng YS. Genomewide Study of
Salivary MicroRNAs for Detection of Oral Cancer. J Dent Res. 2014;93:86S-93S. |
|
|
|
|
|
45.
Shahidi M, Jafari S, Barati M, Mahdipour M, Gholami MS. Predictive value of
salivary microRNA-320a, vascular endothelial growth factor receptor 2, CRP
and IL-6 in Oral lichen planus progression. Inflammopharmacology. 2017 May
13. Online ahead of print. |
|
|
|
|
|
46.
Zahran F, Ghalwash D, Shaker O, Al-Johani K, Scully C. Salivary microRNAs in
oral cancer. Oral Dis. 2015;21:739-747. |
|
|
|
|
|
47.
Lima AM, Meira IA, Soares MS, Bonan PR, Mélo CB, Piagge CS. Delay in
diagnosis of oral cancer: a systematic review. Med Oral Patol Oral Cir Bucal.
2021;26:e815-e824 |
|
|
|
|
|
48.
Irimie AI, Ciocan C, Gulei D, Mehterov N, Atanasov AG, Dudea D,
Berindan-Neagoe I. Current Insights into Oral Cancer Epigenetics. Int J Mol
Sci. 2018;19:670. |
|
|
|
|
|
49.
Alix-Panabières C, Pantel K. Liquid Biopsy: From Discovery to Clinical Application.
Cancer Discov. 2021;11:858-873 |
|
|
|
|
|
50.
Osan C, Chira S, Nutu AM, Braicu C, Baciut M, Korban SS, Berindan-Neagoe I.
The Connection between MicroRNAs and Oral Cancer Pathogenesis: Emerging
Biomarkers in Oral Cancer Management. Genes (Basel). 2021;12:1989. |
|
|
|
|
|
51.
Arantes LMRB, De Carvalho AC, Melendez ME, Lopes Carvalho A. Serum, plasma
and saliva biomarkers for head and neck cancer. Expert Rev Mol Diagn. 2018;18:85-112. |
|